Chesapeake Asset Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.19K Hold
203
﹤0.01% 282
2026
Q1
$3.04K Buy
+203
New +$3.46K ﹤0.01% 297
2025
Q4
Sell
-7,253
Closed -$130K 371
2025
Q3
$130K Sell
7,253
-404
-5% -$5.92K 0.12% 112
2025
Q2
$131K Sell
7,657
-271
-3% -$2.71K 0.12% 110
2025
Q1
$57.4K Hold
7,928
0.05% 117
2024
Q4
$111K Hold
7,928
0.1% 108
2024
Q3
$94K Sell
7,928
-3,072
-28% -$31.8K 0.08% 107
2024
Q2
$102K Buy
+11,000
New +$56.2K 0.1% 98

Other funds holding CORZ

Chesapeake Asset Management's CORZ Position: Q2 2026 in Review

Chesapeake Asset Management held its Core Scientific (CORZ) position steady in Q2 2026 at 203 shares worth $5.19K. The position accounts for ﹤0.01% of the portfolio, ranked #282.

Chesapeake Asset Management first reported a position in CORZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $131K in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Chesapeake Asset Management held 203 shares of Core Scientific worth $5.19K as of Q2 2026.
  • Chesapeake Asset Management left its Core Scientific share count unchanged in Q2 2026.
  • Core Scientific made up ﹤0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #282 holding.
  • Chesapeake Asset Management first reported a position in Core Scientific in Q2 2024 and has held it in 8 quarters since.
  • Chesapeake Asset Management's Core Scientific position peaked at $131K in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.